While exciting in the ability to cure the previously uncurable, the biopharmaceutical revolution presents significant challenges for healthcare payors of all sizes.
For employers and health plans, managing specialty drugs costs is their #1 concern. Even more so, the challenges of precision medicines including cell and gene therapies are frustrating them due to prices exceeding $2 million per treatment coupled with unproven long-term durability of benefits and inability to forecast new treatment claims.
In 2022, the average cost of newly approved drugs is more than $250,000, up significantly from prior years. This pace of cost growth is simply not sustainable and threatens the financial viability of healthcare benefits for millions of patients in the U.S. and many more around the world.
To make matters worse, traditional solutions are not well-equipped to tackle these problems. PayRx is uniquely focused on delivering solutions that challenge old paradigms and break the mold. Our business model is designed to align our interests with that of our customers. When patients, providers and payors succeed, we do.
With decades of success in healthcare, technology and finance, our team of experts are committed to leading the market in providing solutions that outperform all others. That means approaching the challenges of this truly amazing biopharmaceutical revolution through a different lens from that of traditional companies.
For us, creating PayRx was about more than simply building a company. We are paving a new path in the healthcare ecosystem to provide better health outcomes, affordability, and improved access to life-changing and curative therapies.
PayRx is the industry leader in delivering tailored, on-demand precision risk financing solutions and analytics for self-insured employers and health plans to enable greater patient access to high-cost advanced therapies. We leverage data science, purpose-built technology and financial engineering to manage the cost impact of advanced therapies in a unique way that is significantly more affordable, flexible, and provides greater benefits.
Iaculis id magna arcu nibh magna orci nibh. Lorem donec arcu imperdiet sodales ut non praesent tristique est. Nunc vulputate morbi elit convallis. Consectetur etiam enim dignissim arcu elementum. Arcu orci, malesuada proin ac. Ornare odio morbi laoreet.
Mi at diam nunc lorem aliquam quam parturient. Pharetra quam phasellus lorem eget felis sed a, sem. Consectetur donec scelerisque augue ullamcorper enim maecenas. Nulla a in amet, tristique ullamcorper vel. Nullam id fames faucibus ut.
Vel eget malesuada velit ante nibh mauris lorem diam ultrices. Sit feugiat eu, adipiscing bibendum malesuada. Suspendisse turpis commodo magna at. Vestibulum neque integer enim neque condimentum. Faucibus vel nibh condimentum nibh hac aliquam ac.
Ut cursus in fermentum habitant. Tincidunt ipsum vitae hendrerit tincidunt et. Varius sed quis at nascetur pretium lectus. Arcu quisque egestas tincidunt elementum ultricies blandit. Condimentum mauris, duis in ut ac mattis.
